BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Business

  Alure Medical Inc., Minimally-Invasive Plastic Surgery and Aesthetics Device Start-Up, Closes $4.5 Million Series A Private Financing and Announces President and CEO

  April 1, 2008

   · 

  2 min read
• Drug Development

  Cougar Biotechnology, Inc. Announces Agreement with FDA on Special Protocol Assessment for Phase III trial of CB7630

  April 1, 2008

   · 

  4 min read
• Drug Development

  InterMune, Inc. Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update

  April 1, 2008

   · 

  7 min read
• Drug Development

  VIVUS, Inc. Completes Special Protocol Assessment for Phase 3 Efficacy Studies and Reaches Agreement with the FDA on the Safety Study for Luramist

  April 1, 2008

   · 

  8 min read
• Deals

  Church & Dwight Co., Inc. to Acquire Del Pharmaceuticals, Inc. for $380M in Cash

  April 1, 2008

   · 

  5 min read
• Drug Development

  Avant Immunotherapeutics’s Single-Dose Oral Ty800 Vaccine Meets Primary Endpoints in Phase 2 Study

  April 1, 2008

   · 

  8 min read
• Policy

  Labopharm Escalates Tramadol Appeal with FDA

  April 1, 2008

   · 

  3 min read
• Deals

  Tokio Marine Capital to buy Japanese Drug Firm

  April 1, 2008

   · 

  1 min read
• Deals

  India’s Dr. Reddy’s Laboratories Ltd.'s Says to Buy Dowpharma Units

  April 1, 2008

   · 

  3 min read
• Drug Development

  King Pharmaceuticals®, Inc. Presents Positive Results of CorVue(TM) Phase III Clinical Trials

  April 1, 2008

   · 

  6 min read